Anticoagulant Protocols (TSOAC, LMWH)

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

1 post / 0 new
Jason Perry
Jason Perry's picture
Last seen: 1 week 4 days ago
Joined: 07/13/2015 - 13:00
Anticoagulant Protocols (TSOAC, LMWH)


Our Hospitals / Medication Safety Committee are interested in implementing "protocols" to better manage the medication use process surrounding anticoagulants (especially related to patient monitoring). We already do a pretty good job of managing intravenous heparin and argatroban with pharmacist support and our EHR, however we have some potential gaps with our management of TSOACs / LMWHs. Would anyone we wiling to share their protocol, pathway, or order sets for LMWH / TSOAC? For example, do you require indications? Do you have routine laboratory monitoring defaulted in your EHR such as CBC or SrCr daily for three days? Do you see a lot of VTEP heparin combined with TSOACs as a therapeutic duplication with alert fatigue? A recent critical hemoglobin value on a "treatment" dose of LMWH and the ISMP Antithrombotic Self-Assessment is helping prioritize this project. We use SCM Allscripts for our EHR. Thank you!


Jason Perry, PharmD, BCPS, LHRM, CPh
Medication Safety Officer